13
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Effect of Cepharanthin and Cytochalasin D On Platelet Internalization of Anti-Glycoprotein IIb/IIIa Antibodies

, , , , , , , , , , & show all
Pages 23-29 | Received 05 Apr 1994, Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Shosaku Nomura, Tatsunori Matsuzaki, Manabu Yamaoka, Yoshio Ozaki, Minori Nagahama, Chie Yoshimura, Hideo Kagawa, Shirou Nakayama & Shirou Fukuhara. (1999) Genetic Analysis of HLA- and HPA-Typing in Idiopathic (Autoimmune) Thrombocytopenic Purpura Patients Treated with Cepharanthin. Autoimmunity 30:2, pages 99-105.
Read now

Articles from other publishers (5)

Ke Liu, Bixia Hong, Shuqi Wang, Fuxing Lou, Yecheng You, Ruolan Hu, Amna Shafqat, Huahao Fan & Yigang Tong. (2023) Pharmacological Activity of Cepharanthine. Molecules 28:13, pages 5019.
Crossref
Rie Tabata, Chiharu Tabata, Ayako Tazoh & Tomoko Nagai. (2012) Low dose cepharanthine ameliorates immune thrombocytopenic purpura associated with multiple myeloma. International Immunopharmacology 13:3, pages 242-244.
Crossref
Csilla Jámbor, Viviane Reul, Thomas W. Schnider, Priska Degiacomi, Hubert Metzner & Wolfgang C. Korte. (2009) In Vitro Inhibition of Factor XIII Retards Clot Formation, Reduces Clot Firmness, and Increases Fibrinolytic Effects in Whole Blood. Anesthesia & Analgesia 109:4, pages 1023-1028.
Crossref
HIDETO Furuyama, YASUTSUGU Koga, KAZUROU Hamasaki, FUMIKO Kuroki, NORITOMO Itami & YORIKAZU Ishikawa. (1999) Effective treatment of cyclic thrombocytopenia with cepharanthin. Pediatrics International 41:5, pages 584-585.
Crossref
Thomas J. Kunicki & Diane J. Nugent. 1997. Idiotypes in Medicine: Autoimmunity, Infection and Cancer. Idiotypes in Medicine: Autoimmunity, Infection and Cancer 165 187 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.